XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2022   29,493,193      
Beginning balance at Dec. 31, 2022 $ 558,393 $ 29,493 $ 387,171 $ 405,167 $ (263,438)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income 20,807     20,807  
Other Comprehensive Income (Loss) 32,946       32,946
Cash dividends (7,354)     (7,354)  
Issuance of Common Stock for:          
Restricted share grants net (in shares)   80,246      
Restricted Share Grants Net 539 $ 80 459    
Ending balance (in shares) at Mar. 31, 2023   29,573,439      
Ending balance at Mar. 31, 2023 605,331 $ 29,573 387,630 418,620 (230,492)
Beginning balance (in shares) at Dec. 31, 2022   29,493,193      
Beginning balance at Dec. 31, 2022 558,393 $ 29,493 387,171 405,167 (263,438)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income 64,381        
Other Comprehensive Income (Loss) (64,175)        
Ending balance (in shares) at Sep. 30, 2023   29,575,451      
Ending balance at Sep. 30, 2023 538,392 $ 29,575 388,955 447,475 (327,613)
Beginning balance (in shares) at Mar. 31, 2023   29,573,439      
Beginning balance at Mar. 31, 2023 605,331 $ 29,573 387,630 418,620 (230,492)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income 22,123     22,123  
Other Comprehensive Income (Loss) (18,360)       (18,360)
Cash dividends (7,359)     (7,359)  
Issuance of Common Stock for:          
Restricted share grants net (in shares)   (656)      
Restricted Share Grants Net 830   830    
Ending balance (in shares) at Jun. 30, 2023   29,572,783      
Ending balance at Jun. 30, 2023 602,565 $ 29,573 388,460 433,384 (248,852)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income 21,451     21,451  
Other Comprehensive Income (Loss) (78,761)       (78,761)
Cash dividends (7,360)     (7,360)  
Issuance of Common Stock for:          
Restricted share grants net (in shares)   2,668      
Restricted Share Grants Net 497 $ 2 495    
Ending balance (in shares) at Sep. 30, 2023   29,575,451      
Ending balance at Sep. 30, 2023 $ 538,392 $ 29,575 388,955 447,475 (327,613)
Beginning balance (in shares) at Dec. 31, 2023 29,584,709 29,584,709      
Beginning balance at Dec. 31, 2023 $ 663,558 $ 29,585 389,411 461,622 (217,060)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income 19,022     19,022  
Other Comprehensive Income (Loss) (19,895)       (19,895)
Cash dividends (7,955)     (7,955)  
Issuance of Common Stock for:          
Restricted share grants net (in shares)   84,310      
Restricted Share Grants Net 524 $ 84 440    
Ending balance (in shares) at Mar. 31, 2024   29,669,019      
Ending balance at Mar. 31, 2024 $ 655,254 $ 29,669 389,851 472,689 (236,955)
Beginning balance (in shares) at Dec. 31, 2023 29,584,709 29,584,709      
Beginning balance at Dec. 31, 2023 $ 663,558 $ 29,585 389,411 461,622 (217,060)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income 60,600        
Other Comprehensive Income (Loss) $ 42,021        
Ending balance (in shares) at Sep. 30, 2024 29,679,466 29,679,466      
Ending balance at Sep. 30, 2024 $ 744,563 $ 29,679 391,583 498,340 (175,039)
Beginning balance (in shares) at Mar. 31, 2024   29,669,019      
Beginning balance at Mar. 31, 2024 655,254 $ 29,669 389,851 472,689 (236,955)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income 20,530     20,530  
Other Comprehensive Income (Loss) 19,086       19,086
Cash dividends (7,963)     (7,963)  
Issuance of Common Stock for:          
Restricted share grants net (in shares)   10,229      
Restricted Share Grants Net 914 $ 10 904    
Ending balance (in shares) at Jun. 30, 2024   29,679,248      
Ending balance at Jun. 30, 2024 687,821 $ 29,679 390,755 485,256 (217,869)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income 21,048     21,048  
Other Comprehensive Income (Loss) 42,830       42,830
Cash dividends (7,964)     (7,964)  
Issuance of Common Stock for:          
Restricted share grants net (in shares)   218      
Restricted Share Grants Net $ 828 $ 0 828    
Ending balance (in shares) at Sep. 30, 2024 29,679,466 29,679,466      
Ending balance at Sep. 30, 2024 $ 744,563 $ 29,679 $ 391,583 $ 498,340 $ (175,039)